Navigation Links
Boehringer Ingelheim Unveils Diabetes Pipeline
Date:6/6/2009

he management of this prevalent disease," said Dr. Thor Voigt, senior vice president, Medicine and Drug Regulatory Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Type 2 diabetes is a progressive chronic condition that frequently requires long-term treatment. A range of treatment options and combination regimens are needed so physicians can tailor therapy to the individual patient needs. We are now awaiting results from additional ongoing studies which will further assess the full potential of linagliptin for the treatment of type 2 diabetes."

DPP-4 inhibitors are a newer class of oral hypoglycemics that target the incretin hormones GLP-1 and GIP, which are believed to be involved with regulating blood sugar.(2)

Linagliptin is a compound discovered by Boehringer Ingelheim and is being developed as an oral once-daily tablet for the treatment of type 2 diabetes. The compound is currently being studied in five pivotal Phase III clinical trials including more than 4,000 patients. These trials are fully recruited and underway globally and in many states across the U.S.(3)

Boehringer Ingelheim is also investigating sodium-dependent glucose co-transporter-2 inhibitors (SGLT-2 inhibitors), which are a new, emerging class of antidiabetic compounds that block tubular reabsorption of glucose in the kidney.(4) Phase IIb clinical trials for this innovative approach to diabetes treatment are underway. There are currently no SGLT-2 inhibitors approved by the U.S. Food and Drug Administration (FDA).

About the linagliptin (BI 1356) Phase II study

The aim of the 12-week, international, randomized, double-blind placebo-controlled study was to assess the efficacy and safety profile of linagliptin as add-on therapy in patients with type 2 diabetes who were failing to achieve glycemic control despite being treated with metformin.(1) The primary endpoint was the change in HbA1c from bas
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
4. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
5. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
6. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
7. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
8. Oregon Tourism Commission Unveils New Online Customer Service Training Program
9. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
10. Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
11. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Ironshore Pharmaceuticals & Development, Inc. ("Ironshore") ... company specializing in personalized medicine, to participate in ... to evaluate the safety and efficacy of HLD-200, ... disorder (ADHD). This is Restore,s second clinical trial ... partnered with Ironshore in 2014 and continues to ...
(Date:8/3/2015)... JORDAN, Utah , Aug. 3, 2015  BC Technical, ... has acquired Ohio Valley Medical Systems, one of the ... systems.  The addition of Ohio Valley Medical Systems allows ... now include Hitachi MRI.   "We couldn,t ... Alvarez , President and CEO of BC Technical. "The ...
(Date:8/3/2015)... AUSTIN, Texas, Aug. 3, 2015  Luminex Corporation (NASDAQ: ... second quarter ended June 30, 2015.  Financial and operating ... , Increased second quarter 2015 revenue by 6 percent ... , Grew second quarter 2015 assay revenue by ... second quarter of 2014. , Increased Q2 2015 ...
Breaking Medicine Technology:Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2BC Technical Acquires Ohio Valley Medical Systems 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics heaven,” “mecca for make-up,” ... Naimie’s Beauty Center in LA. Now MENAJI is part of that experience acting as ... Beauty Center has been a favorite of makeup artists and hair pros as well ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new ... America IT reseller channel will grow at least 6 percent in 2015, as ... pace and greater than their OEM/vendor partners. , The 2112 Group’s 2015 ...
(Date:8/4/2015)... Tel Aviv, Israel (PRWEB) , ... August 04, ... ... company, today announced the launch of a new product suite designed to provide ... tracks signals and trends based on multi-sourced and cross-referenced data from regulatory filings ...
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... mortgage lender specializing in healthcare finance, announced the closing of a $118 million ... two campus health system located in Smithfield and Clayton, North Carolina. JHSC ...
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on ... research team, can now be accessed at http://www.AISHealth.com . The data is free ... Health Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
Breaking Medicine News(10 mins):Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2
... , ... in online-based medical transcription, has tapped Randy Olver as its new CEO, effective immediately. ... (Vocus) November 5, 2009 -- ... its new CEO, effective immediately., , , , ,Emdat’s founding partners, who remain actively involved ...
... VOLC ), a leader in the development, manufacture and ... and peripheral artery disease, today reported revenues of $53.9 million ... for the quarter ended September 30, 2009, represent an increase ... third quarter of 2008. Revenues for the third quarter of ...
... 5 STINSON Brand Innovation is offering a custom e-book, "Notes on ... 8-14. , The e-book is one in a series of e-books titled ... on C la s ... no charge at http://www.stinsonbrandinnovation.com/ebooks/SBI_NotesOnNursing.htm , "This is a way we ...
... human genomes could be sequenced next year, company says , ... says it has developed a lower-cost DNA platforming sequence. ... full human genomes, was published Nov. 5 in Science ... cost for three genomic DNA nanoarrays ranged from $1,726 to ...
... A drug already approved for the treatment of lymphoma may ... in children and teens, according to an early-stage study published ... The study drug, Bortezomib, was found to be effective against ... While key experiments were in animals, the cancer studied closely ...
... -- Picture it: One jerk in a bar spends the ... of the evening, the women aren,t receptive to even the ... in evolutionary theory. Males increase their fitness by acquiring more ... and therein lies the conflict. Researchers at Binghamton ...
Cached Medicine News:Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 3Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 4Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 5Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 6Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 7Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 8Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 9Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 10Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 11Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 12Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 13Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 14Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Approved lymphoma drug shows promise in early tests against bone cancer 2Health News:Mom was right: Nice guys don't always finish last 2
... is specifically designed to work with the ... is a small tank blotter that incorporates ... (low buffer requirements and fast transfer rates), ... semi-dry blotting such as arcing and buffer ...
... Blot Module allows you to easily transfer proteins ... fits neatly into the XCell SureLock and XCell ... assembly. It requires less than 200 ml of ... Tough platinized titanium and stainless steel electrodes create ...
... The GENIE is the proven electrophoretic ... the ultimate in field uniformity. Its design ... the electrodes which, when coupled with a ... battery charger, creates a high field in ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: